Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial-Reference-Cited by-同舟云学术

Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial

Published:2000-12 Issue:2 Volume:37 Page:95-104
ISSN:0378-5122
Container-title:Maturitas
language:en
Short-container-title:Maturitas

Author:

Cornu Catherine,Mercier Catherine,Ffrench Patrick,Bully Chantal,Pugeat Michel,Cousin Patrice,Riou Jean-Paul,Bajart Laure,Orgiazzi Jacques,Pommet-Nicot Catherine,Darsy Paul,Boissel Jean-Pierre,Berthezène François

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,General Biochemistry, Genetics and Molecular Biology

Reference9 articles.

1. Evaluation quantitative du risque cardiovasculaire associé au traitement hormonal substitutif de la ménopause;Scarabin;Arch. Mal. Coeur,1993

2. Oestrogen therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence;Stampfer;Preventive Med.,1991

3. Randomized trial of oestrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women;Hulley;J. Am. Med. Assoc.,1998

4. Diabetes mortality. Diabetes Mellitus;Elkoe,1988

5. Diabetes and atherosclerosis: epidemiological considerations;Haffner,1993

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Transdermal 17β-Estradiol + Norethisterone Acetate on Cardiovascular Disease Risk Factors in Postmenopausal Women: A Meta-analysis of Data From Randomized, Controlled Trials;Clinical Therapeutics;2023-11

2. The effect of 17beta-estradiol plus norethisterone acetate on anthropometric indices: A systematic review and meta-analysis of randomized controlled trials;European Journal of Obstetrics & Gynecology and Reproductive Biology;2023-08

3. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group;Maturitas;2022-12

4. Transdermal estrogen therapy in menopausal women at increased risk for thrombotic events: a scoping review;Menopause;2022-01-14

5. Menopause, hormone therapy and diabetes;Climacteric;2017-01-02